NEJM August 2026 Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica
This Week In Medicine

NEJM August 2026 Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica

August 14, 20261 min
Play episode

No transcript for this episode yet

You can still listen to it in the player. On episodes with a transcript, you can tap any word to see its meaning.